articleTop 1% cited
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Gut · 2012 · Vol. 62(4) · pp. 531–539
Henri Duboc(Assistance Publique – Hôpitaux de Paris)Sylvie Rajca(Sorbonne Université)Dominique Rainteau(Hôpital Saint-Antoine)David BenarousMarie-Anne Maubert(Assistance Publique – Hôpitaux de Paris)Elodie Quervain(Laboratoire des Biomolécules)Ginette Thomas(Sorbonne Université)Véronique Barbu(Sorbonne Université)Lydie Humbert(Hôpital Saint-Antoine)Guillaume Despras(Laboratoire des Biomolécules)Chantal Bridonneau(Microbiologie de l’alimentation au service de la santé)Fabien Dumetz(Microbiologie de l’alimentation au service de la santé)Jean-Pierre Grill(Laboratoire des Biomolécules)J. Masliah(Laboratoire des Biomolécules)Laurent Beaugerie(Laboratoire des Biomolécules)Jacques Cosnes(Sorbonne Université)Olivier Chazouillères(Assistance Publique – Hôpitaux de Paris)Raoul Poupon(Hôpital Saint-Antoine)Claude Wolf(Inserm)Jean‐Maurice Mallet(Laboratoire des Biomolécules)Philippe Langella(Microbiologie de l’alimentation au service de la santé)Germain Trugnan(Inserm)Harry Sokol(Hôpital Saint-Antoine)Philippe Seksik✉(Laboratoire des Biomolécules)
Abstract
Impaired microbiota enzymatic activity observed in IBD-associated dysbiosis leads to modifications in the luminal BA pool composition. Altered BA transformation in the gut lumen can erase the anti-inflammatory effects of some BA species on gut epithelial cells and could participate in the chronic inflammation loop of IBD.
Drug Transport and Resistance MechanismsGut microbiota and healthInflammatory Bowel DiseaseDysbiosisGut floraInflammationDeoxycholic acidFecesInternal medicineInflammatory bowel diseaseImmunologyChemistryMicrobiology
MeSH terms
AnimalsBile Acids and SaltsChromatography, High Pressure LiquidColonic NeoplasmsEnzyme-Linked Immunosorbent AssayFecesHumansInflammatory Bowel DiseasesChi-Square DistributionStatistics, NonparametricArea Under CurveCell Line, TumorMiceTandem Mass SpectrometryMetagenome
Citations
904
FWCI
13.15
field-weighted impact
References
57
Percentile
99%
vs. same field & year
Citations per year
Cited by
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Gut · 2020 · 1,207 citations
Fungal microbiota dysbiosis in IBD
Gut · 2016 · 1,302 citations
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Biomedicine & Pharmacotherapy · 2023 · 347 citations
References
Microbes in Gastrointestinal Health and Disease
Gastroenterology · 2008 · 1,367 citations
Bile salt biotransformations by human intestinal bacteria
Journal of Lipid Research · 2005 · 2,751 citations
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Proceedings of the National Academy of Sciences · 2007 · 4,550 citations
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
Gut · 2006 · 3,101 citations
Bile acid transporters
Journal of Lipid Research · 2009 · 656 citations
<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Proceedings of the National Academy of Sciences · 2008 · 4,255 citations
Bile acids as regulatory molecules
Journal of Lipid Research · 2009 · 684 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
